The presence of CD4+ T lymphocytes infiltrating tumors has been linked to a reduced likelihood of relapse-free survival in translocation renal cell carcinoma (RCC) [24]. The gene discussed is CD4; the disease is MIT family translocation renal cell carcinoma.